FRI0044 Exceeding predefined thresholds for mri bone oedema and erosion and haq-di can predict relapse after withdrawal of all treatment in mtx-naÏve patients with ra in remission after 12 months of abatacept therapy in the avert trial

H.a. Ahmad; J.f. Baker; M. Østergaard; P. Emery; T. Huizinga; Y. Elbez; S. Banerjee; P.g. Conaghan

doi:10.1136/annrheumdis-2018-eular.2117

FRI0044 Exceeding predefined thresholds for mri bone oedema and erosion and haq-di can predict relapse after withdrawal of all treatment in mtx-naÏve patients with ra in remission after 12 months of abatacept therapy in the avert trial

H.a. Ahmad, J.f. Baker, M. Østergaard, P. Emery, T. Huizinga, Y. Elbez, S. Banerjee, P.g. Conaghan

Department of Clinical Medicine

13 Citations (Scopus)

Original language	English
Journal	Annals of the Rheumatic Diseases
Volume	77
Issue number	2
Pages (from-to)	568-569
Number of pages	2
ISSN	0003-4967
DOIs	https://doi.org/10.1136/annrheumdis-2018-eular.2117
Publication status	Published - 2018

Access to Document

10.1136/annrheumdis-2018-eular.2117

568.2.full.pdfFinal published version, 422 KB

Cite this

Ahmad, H. A., Baker, J. F., Østergaard, M., Emery, P., Huizinga, T., Elbez, Y., Banerjee, S., & Conaghan, P. G. (2018). FRI0044 Exceeding predefined thresholds for mri bone oedema and erosion and haq-di can predict relapse after withdrawal of all treatment in mtx-naÏve patients with ra in remission after 12 months of abatacept therapy in the avert trial. Annals of the Rheumatic Diseases, 77(2), 568-569. https://doi.org/10.1136/annrheumdis-2018-eular.2117

FRI0044 Exceeding predefined thresholds for mri bone oedema and erosion and haq-di can predict relapse after withdrawal of all treatment in mtx-naÏve patients with ra in remission after 12 months of abatacept therapy in the avert trial. / Ahmad, H.a.; Baker, J.f.; Østergaard, M. et al.
In: Annals of the Rheumatic Diseases, Vol. 77, No. 2, 2018, p. 568-569.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Ahmad, HA, Baker, JF, Østergaard, M, Emery, P, Huizinga, T, Elbez, Y, Banerjee, S & Conaghan, PG 2018, 'FRI0044 Exceeding predefined thresholds for mri bone oedema and erosion and haq-di can predict relapse after withdrawal of all treatment in mtx-naÏve patients with ra in remission after 12 months of abatacept therapy in the avert trial', Annals of the Rheumatic Diseases, vol. 77, no. 2, pp. 568-569. https://doi.org/10.1136/annrheumdis-2018-eular.2117

Ahmad HA, Baker JF, Østergaard M, Emery P, Huizinga T, Elbez Y et al. FRI0044 Exceeding predefined thresholds for mri bone oedema and erosion and haq-di can predict relapse after withdrawal of all treatment in mtx-naÏve patients with ra in remission after 12 months of abatacept therapy in the avert trial. Annals of the Rheumatic Diseases. 2018;77(2):568-569. doi: 10.1136/annrheumdis-2018-eular.2117

@article{32ab9f2cbf5648ee88c8ee7da27796e9,

title = "FRI0044 Exceeding predefined thresholds for mri bone oedema and erosion and haq-di can predict relapse after withdrawal of all treatment in mtx-na{\"I}ve patients with ra in remission after 12 months of abatacept therapy in the avert trial",

author = "H.a. Ahmad and J.f. Baker and M. {\O}stergaard and P. Emery and T. Huizinga and Y. Elbez and S. Banerjee and P.g. Conaghan",

year = "2018",

doi = "10.1136/annrheumdis-2018-eular.2117",

language = "English",

volume = "77",

pages = "568--569",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "2",

}

TY - ABST

T1 - FRI0044 Exceeding predefined thresholds for mri bone oedema and erosion and haq-di can predict relapse after withdrawal of all treatment in mtx-naÏve patients with ra in remission after 12 months of abatacept therapy in the avert trial

AU - Ahmad, H.a.

AU - Baker, J.f.

AU - Østergaard, M.

AU - Emery, P.

AU - Huizinga, T.

AU - Elbez, Y.

AU - Banerjee, S.

AU - Conaghan, P.g.

PY - 2018

Y1 - 2018

U2 - 10.1136/annrheumdis-2018-eular.2117

DO - 10.1136/annrheumdis-2018-eular.2117

M3 - Conference abstract in journal

SN - 0003-4967

VL - 77

SP - 568

EP - 569

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 2

ER -